Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucocorticoid-induced osteoporosis.

J D Ringe1

  • 1Geriatrische Klinik, Städtisches Krankehaus, Akademisches Lehrkrankenhaus, Universität Köln, Leverkusen, Federal Repubic of Germany.

Clinical Rheumatology
|June 1, 1989
PubMed
Summary

Glucocorticoid-induced osteoporosis (GC-OP) is a significant secondary osteoporosis. Salmon calcitonin (sCT) treatment improved bone mineral content and reduced pain in patients with GC-OP.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Male osteoporosis].

Zeitschrift fur Rheumatologie·2016
Same author

The position of strontium ranelate in today's management of osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Management of osteoporosis of the oldest old.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2014
Same author

[Vitamin D deficiency in Germany, is it a danger for increased morbidityand mortality?].

MMW Fortschritte der Medizin·2013
Same author

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2013
Same author

[Combination of alendronate plus alfacalcidol in the treatment of osteoporosis. Rationale, preclinical data and clinical evidence].

MMW Fortschritte der Medizin·2013

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Pharmacology

Background:

  • Glucocorticoid-induced osteoporosis (GC-OP) is a major secondary osteoporosis.
  • Key mechanisms include inhibited osteoblast formation, stimulated osteoclast resorption, and impaired calcium absorption.
  • Factors like dosage, duration, age, and sex influence GC-OP development.

Purpose of the Study:

  • To investigate the efficacy of salmon calcitonin (sCT) in treating manifest GC-OP.
  • To evaluate the impact of sCT on bone mineral content and pain in patients with chronic obstructive lung disease on prednisone therapy.

Main Methods:

  • A randomized controlled trial involving 36 patients with GC-OP.
  • 18 patients received 100 U sCT subcutaneously every second day.
  • 18 patients served as untreated controls.

Main Results:

  • The sCT group showed a significant reduction in pain.
  • Bone mineral content in the distal radius increased by 2.7% in the sCT group over six months.
  • The control group experienced a 3.5% decrease in bone mineral content (p < 0.001).

Conclusions:

  • Salmon calcitonin (sCT) is effective in improving bone mineral density and alleviating pain in patients with GC-OP.
  • sCT offers a potential therapeutic strategy to counteract the detrimental effects of long-term glucocorticoid use on bone health.

Related Experiment Videos